Reduction of size of myocardial infarction with nicorandil, a new antianginal drug, after coronary artery occlusion in dogs. 1988

T Endo, and J Nejima, and K Kiuchi, and S Fujita, and K Kikuchi, and H Hayakawa, and H Okumura
First Department of Internal Medicine, Nippon Medical School, Japan.

The effects of nicorandil, a new antianginal drug, on size of myocardial infarction were studied in anesthetized, open-chest dogs after left anterior descending coronary artery occlusion. To quantify the extent of the hypoperfused zone, 99mTc-albumin microspheres were injected into the left atrium 1 min after occlusion. Fifteen minutes after occlusion, dogs were randomly assigned to a control group or a nicorandil-treated group that received immediately after assignments 100 micrograms/kg of nicorandil followed by a continuous infusion of 30 micrograms/kg/min for 6 h. Six hours after occlusion, the left ventricle was cut into 3 mm thick slices for triphenyltetrazolium chloride staining and autoradiography. The extent of the hypoperfused zone (26.1% +/- 3.1% of the left ventricle in the control vs. 23.2% +/- 3.7% in the treated group, mean +/- SEM) was not different between the two groups. The ratio of the extent of myocardial necrosis to the extent of the hypoperfused zone was significantly smaller in the treated group (64.3% +/- 7.2%, n = 7, p less than 0.05) than in the control group (92.6% +/- 9.2%, n = 7). Thus, nicorandil administered early after coronary artery occlusion reduced the size of myocardial infarction by 31%.

UI MeSH Term Description Entries
D008297 Male Males
D009203 Myocardial Infarction NECROSIS of the MYOCARDIUM caused by an obstruction of the blood supply to the heart (CORONARY CIRCULATION). Cardiovascular Stroke,Heart Attack,Myocardial Infarct,Cardiovascular Strokes,Heart Attacks,Infarct, Myocardial,Infarction, Myocardial,Infarctions, Myocardial,Infarcts, Myocardial,Myocardial Infarctions,Myocardial Infarcts,Stroke, Cardiovascular,Strokes, Cardiovascular
D009536 Niacinamide An important compound functioning as a component of the coenzyme NAD. Its primary significance is in the prevention and/or cure of blacktongue and PELLAGRA. Most animals cannot manufacture this compound in amounts sufficient to prevent nutritional deficiency and it therefore must be supplemented through dietary intake. Nicotinamide,Vitamin B 3,Vitamin PP,3-Pyridinecarboxamide,Enduramide,Nicobion,Nicotinsäureamid Jenapharm,Papulex,Vitamin B3,3 Pyridinecarboxamide,B 3, Vitamin,B3, Vitamin,Jenapharm, Nicotinsäureamid
D003327 Coronary Disease An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels. Coronary Heart Disease,Coronary Diseases,Coronary Heart Diseases,Disease, Coronary,Disease, Coronary Heart,Diseases, Coronary,Diseases, Coronary Heart,Heart Disease, Coronary,Heart Diseases, Coronary
D004285 Dogs The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065) Canis familiaris,Dog
D005260 Female Females
D006439 Hemodynamics The movement and the forces involved in the movement of the blood through the CARDIOVASCULAR SYSTEM. Hemodynamic
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D014665 Vasodilator Agents Drugs used to cause dilation of the blood vessels. Vasoactive Antagonists,Vasodilator,Vasodilator Agent,Vasodilator Drug,Vasorelaxant,Vasodilator Drugs,Vasodilators,Vasorelaxants,Agent, Vasodilator,Agents, Vasodilator,Antagonists, Vasoactive,Drug, Vasodilator,Drugs, Vasodilator
D020108 Nicorandil A derivative of the NIACINAMIDE that is structurally combined with an organic nitrate. It is a potassium-channel opener that causes vasodilatation of arterioles and large coronary arteries. Its nitrate-like properties produce venous vasodilation through stimulation of guanylate cyclase. 2-Nicotinamidoethyl Nitrate,2-Nicotinamidethyl Nitrate,Adancor,Dancor,Ikorel,SG-75,2 Nicotinamidethyl Nitrate,2 Nicotinamidoethyl Nitrate,Nitrate, 2-Nicotinamidethyl,Nitrate, 2-Nicotinamidoethyl,SG 75,SG75

Related Publications

T Endo, and J Nejima, and K Kiuchi, and S Fujita, and K Kikuchi, and H Hayakawa, and H Okumura
January 1985, Journal of cardiovascular pharmacology,
T Endo, and J Nejima, and K Kiuchi, and S Fujita, and K Kikuchi, and H Hayakawa, and H Okumura
February 1984, British journal of pharmacology,
T Endo, and J Nejima, and K Kiuchi, and S Fujita, and K Kikuchi, and H Hayakawa, and H Okumura
November 1973, Annals of internal medicine,
T Endo, and J Nejima, and K Kiuchi, and S Fujita, and K Kikuchi, and H Hayakawa, and H Okumura
July 1986, Anesthesia and analgesia,
T Endo, and J Nejima, and K Kiuchi, and S Fujita, and K Kikuchi, and H Hayakawa, and H Okumura
May 1990, American heart journal,
T Endo, and J Nejima, and K Kiuchi, and S Fujita, and K Kikuchi, and H Hayakawa, and H Okumura
March 1986, Radiology,
T Endo, and J Nejima, and K Kiuchi, and S Fujita, and K Kikuchi, and H Hayakawa, and H Okumura
May 1978, Circulation,
T Endo, and J Nejima, and K Kiuchi, and S Fujita, and K Kikuchi, and H Hayakawa, and H Okumura
June 1979, Circulation,
T Endo, and J Nejima, and K Kiuchi, and S Fujita, and K Kikuchi, and H Hayakawa, and H Okumura
October 1972, The Journal of clinical investigation,
T Endo, and J Nejima, and K Kiuchi, and S Fujita, and K Kikuchi, and H Hayakawa, and H Okumura
October 1990, American heart journal,
Copied contents to your clipboard!